Ependymoblastoma (EBL) is a rare malignant CNS tumor of early childhood, listed as a subgroup of primitive neuroectodermal tumors (PNET) in the 2007 WHO Classification of Tumours of the Central Nervous System. Histologically, EBL can be defined by multilayered, mitotically active "ependymoblastic" rosettes with central lumen as a histological hallmark. The prognosis seems to be far inferior to other embryonal CNS tumors, and known clinical and MRI characteristics of EBL are based on scattered case reports. We present and discuss two uncommon cases of histopathologically confirmed ependymoblastoma that both seem to originate from the brainstem.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/pbc.24915 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development of a simple prediction model for tracheostomy requirement after surgical resection of medulloblastoma in children.
BMC Res Notes
January 2025
Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Objective: Postoperative tracheostomy is a significant complication following medulloblastoma (MB) resection. This study aimed to develop a predictive model for postoperative tracheostomy requirement in children undergoing MB surgical resection. This model was derived as a side product of a larger research project analyzing surgical outcomes in pediatric MB patients.
View Article and Find Full Text PDFZIC1 is a context-dependent medulloblastoma driver in the rhombic lip.
Nat Genet
January 2025
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Transcription factors are frequent cancer driver genes, exhibiting noted specificity based on the precise cell of origin. We demonstrate that ZIC1 exhibits loss-of-function (LOF) somatic events in group 4 (G4) medulloblastoma through recurrent point mutations, subchromosomal deletions and mono-allelic epigenetic repression (60% of G4 medulloblastoma). In contrast, highly similar SHH medulloblastoma exhibits distinct and diametrically opposed gain-of-function mutations and copy number gains (20% of SHH medulloblastoma).
View Article and Find Full Text PDFCP ANGLE MEDULLOBLASTOMA WITH SUPRATENTORIAL DROP METS.
J Ayub Med Coll Abbottabad
November 2024
Akbar Niazi Teaching Hospital, IMDC, Islamabad.
Article Synopsis
- * A 17-year-old male presented with headaches and walking difficulties, leading to the discovery of a CPA lesion, which was surgically removed and diagnosed as medulloblastoma; he then received chemo-radiotherapy.
- * After two years, the patient experienced new headaches and seizures, resulting in the identification of a metastatic tumor in the temporal lobe, also confirmed as medulloblastoma.
Human stem cell models to unravel brain cancer.
BMC Cancer
November 2024
Division of Pediatric Neurosurgery, Riley Hospital for Children, Indianapolis, IN, USA.
Article Synopsis
- * Human-derived brain tumor cell lines also face challenges, making them inadequate for certain pre-clinical modeling tasks.
- * The article advocates for utilizing human stem cell-based models, such as two-dimensional cultures and three-dimensional organoids, as promising alternatives to traditional models for better understanding and treating brain tumors like glioblastoma and medulloblastoma.
Differential Replication and Oncolytic Effects of Zika Virus in Aggressive CNS Tumor Cells: Insights from Organoid and Tumoroid Models.
Viruses
November 2024
Human Genome and Stem Cell Research Center (CEGH-CEL), Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, Cidade Universitária, São Paulo 05508-090, SP, Brazil.
Article Synopsis
- CNS cancers like Glioblastoma and pediatric tumors face significant treatment challenges due to their poor response to conventional therapies such as radiation and chemotherapy.* -
- Recent research highlights the potential of the Zika virus (ZIKV) as an oncolytic treatment, showing its ability to infect and kill malignant CNS tumor cells while having a preference for tumor rather than normal cells.* -
- Experiments using hybrid co-culture models demonstrated that ZIKV replication was enhanced in tumor cells compared to normal cells, leading to notable reductions in the number of certain tumor types, although not uniformly effective across all cancers.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!